IRCT201706075623N120
Completed
Phase 3
Clinical trial of the effect of chromium supplementation compared with the placebo on metabolic profiles in women with polycystic ovary syndrome of IVF candidate
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Arak University of Medical Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with polycystic ovary syndrome
- •Individuals aged 18 to 40 years old
Exclusion Criteria
- •Androgen\-secreting tumors
- •Thyroid dysfunction
- •Diabetes or impaired glucose tolerance
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of chromium supplementation in treatment of patients with polycystic ovary syndrome candidate for IVFIRCT20170513033941N32Shahid Beheshti University of Medical Sciences40
Completed
Phase 3
Effect of chromium supplementation in treatment of coronary heart diseaseIRCT20170513033941N30Kashan University of Medical Sciences70
Completed
Phase 3
Effect of combined chromium and carnitine supplementation in treatment of women with polycystic ovary syndromeIRCT20170513033941N38Arak University of Medical Sciences60
Completed
Phase 3
Effect of combined chromium and carnitine supplementation in treatment of women with polycystic ovary syndromeIRCT2017090533941N24Vice chancellor for research, Arak University of Medical Sciences60
Recruiting
Phase 3
Effect of the therapeutic effect of chromium supplementation with doses of 400 and 600 micrograms on body mass indexPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20210515051298N1Shahre-kord University of Medical Sciences120